Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2015M3A9E6028412)
Korea National Institute of Health (HI20C0386)
- License Information
-
More Information
Article History
Received: 30 November 2021
Revised: 28 January 2022
Accepted: 2 February 2022
First Online: 24 March 2022
Declarations
:
: CHJ owns shares of AcesoStem Biostrategies Inc. The other authors indicated no potential conflicts of interest.
: The study was approved by the Seoul Metropolitan Government Seoul National University Boramae Medical Center Institutional Review Board (IRB No. 30–2019-25). Informed Consent was obtained from all patients before performing the study.
